Logo image of IPAR

INTERPARFUMS INC (IPAR) Stock Fundamental Analysis

USA - NASDAQ:IPAR - US4583341098 - Common Stock

98.83 USD
+0.46 (+0.47%)
Last: 10/20/2025, 8:00:02 PM
98.83 USD
0 (0%)
After Hours: 10/20/2025, 8:00:02 PM
Fundamental Rating

6

Overall IPAR gets a fundamental rating of 6 out of 10. We evaluated IPAR against 33 industry peers in the Personal Care Products industry. IPAR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IPAR has a correct valuation and a medium growth rate. These ratings would make IPAR suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year IPAR was profitable.
IPAR had a positive operating cash flow in the past year.
IPAR had positive earnings in each of the past 5 years.
In the past 5 years IPAR always reported a positive cash flow from operatings.
IPAR Yearly Net Income VS EBIT VS OCF VS FCFIPAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

IPAR has a Return On Assets of 10.31%. This is amongst the best in the industry. IPAR outperforms 81.82% of its industry peers.
IPAR's Return On Equity of 19.18% is amongst the best of the industry. IPAR outperforms 84.85% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.62%, IPAR belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
IPAR had an Average Return On Invested Capital over the past 3 years of 17.76%. This is above the industry average of 12.77%.
Industry RankSector Rank
ROA 10.31%
ROE 19.18%
ROIC 16.62%
ROA(3y)10.68%
ROA(5y)8.79%
ROE(3y)21.16%
ROE(5y)17.18%
ROIC(3y)17.76%
ROIC(5y)14.62%
IPAR Yearly ROA, ROE, ROICIPAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

IPAR has a better Profit Margin (11.03%) than 90.91% of its industry peers.
In the last couple of years the Profit Margin of IPAR has grown nicely.
The Operating Margin of IPAR (19.21%) is better than 93.94% of its industry peers.
IPAR's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 56.34%, IPAR is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
IPAR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.21%
PM (TTM) 11.03%
GM 56.34%
OM growth 3Y3.91%
OM growth 5Y5.52%
PM growth 3Y4.43%
PM growth 5Y6.05%
GM growth 3Y0.16%
GM growth 5Y0.24%
IPAR Yearly Profit, Operating, Gross MarginsIPAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

IPAR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for IPAR has been increased compared to 1 year ago.
The number of shares outstanding for IPAR has been increased compared to 5 years ago.
IPAR has a better debt/assets ratio than last year.
IPAR Yearly Shares OutstandingIPAR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IPAR Yearly Total Debt VS Total AssetsIPAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

IPAR has an Altman-Z score of 5.36. This indicates that IPAR is financially healthy and has little risk of bankruptcy at the moment.
IPAR has a Altman-Z score of 5.36. This is amongst the best in the industry. IPAR outperforms 81.82% of its industry peers.
IPAR has a debt to FCF ratio of 1.61. This is a very positive value and a sign of high solvency as it would only need 1.61 years to pay back of all of its debts.
IPAR has a Debt to FCF ratio of 1.61. This is amongst the best in the industry. IPAR outperforms 87.88% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that IPAR is not too dependend on debt financing.
The Debt to Equity ratio of IPAR (0.24) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.61
Altman-Z 5.36
ROIC/WACC1.98
WACC8.4%
IPAR Yearly LT Debt VS Equity VS FCFIPAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IPAR has a Current Ratio of 2.96. This indicates that IPAR is financially healthy and has no problem in meeting its short term obligations.
IPAR's Current ratio of 2.96 is fine compared to the rest of the industry. IPAR outperforms 72.73% of its industry peers.
IPAR has a Quick Ratio of 1.69. This is a normal value and indicates that IPAR is financially healthy and should not expect problems in meeting its short term obligations.
IPAR has a Quick ratio of 1.69. This is in the better half of the industry: IPAR outperforms 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 1.69
IPAR Yearly Current Assets VS Current LiabilitesIPAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

IPAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.63%, which is quite good.
Measured over the past years, IPAR shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.27% on average per year.
The Revenue has been growing slightly by 7.04% in the past year.
Measured over the past years, IPAR shows a quite strong growth in Revenue. The Revenue has been growing by 15.27% on average per year.
EPS 1Y (TTM)16.63%
EPS 3Y22.78%
EPS 5Y22.27%
EPS Q2Q%-13.16%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y18.2%
Revenue growth 5Y15.27%
Sales Q2Q%-2.42%

3.2 Future

The Earnings Per Share is expected to grow by 6.32% on average over the next years.
IPAR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y1.3%
EPS Next 2Y5.2%
EPS Next 3Y6.32%
EPS Next 5YN/A
Revenue Next Year2.09%
Revenue Next 2Y3.68%
Revenue Next 3Y4.43%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IPAR Yearly Revenue VS EstimatesIPAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
IPAR Yearly EPS VS EstimatesIPAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

IPAR is valuated rather expensively with a Price/Earnings ratio of 19.30.
Compared to the rest of the industry, the Price/Earnings ratio of IPAR indicates a somewhat cheap valuation: IPAR is cheaper than 66.67% of the companies listed in the same industry.
IPAR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.69.
A Price/Forward Earnings ratio of 17.11 indicates a rather expensive valuation of IPAR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IPAR indicates a somewhat cheap valuation: IPAR is cheaper than 60.61% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, IPAR is valued a bit cheaper.
Industry RankSector Rank
PE 19.3
Fwd PE 17.11
IPAR Price Earnings VS Forward Price EarningsIPAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IPAR is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
69.70% of the companies in the same industry are more expensive than IPAR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.03
EV/EBITDA 10.07
IPAR Per share dataIPAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of IPAR may justify a higher PE ratio.
PEG (NY)14.81
PEG (5Y)0.87
EPS Next 2Y5.2%
EPS Next 3Y6.32%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.33%, IPAR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.87, IPAR pays a better dividend. On top of this IPAR pays more dividend than 84.85% of the companies listed in the same industry.
IPAR's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.33%

5.2 History

On average, the dividend of IPAR grows each year by 22.18%, which is quite nice.
IPAR has been paying a dividend for at least 10 years, so it has a reliable track record.
IPAR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)22.18%
Div Incr Years4
Div Non Decr Years4
IPAR Yearly Dividends per shareIPAR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

61.79% of the earnings are spent on dividend by IPAR. This is not a sustainable payout ratio.
The dividend of IPAR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y5.2%
EPS Next 3Y6.32%
IPAR Yearly Income VS Free CF VS DividendIPAR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
IPAR Dividend Payout.IPAR Dividend Payout, showing the Payout Ratio.IPAR Dividend Payout.PayoutRetained Earnings

INTERPARFUMS INC

NASDAQ:IPAR (10/20/2025, 8:00:02 PM)

After market: 98.83 0 (0%)

98.83

+0.46 (+0.47%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners63.63%
Inst Owner Change0.24%
Ins Owners43.52%
Ins Owner Change-0.55%
Market Cap3.17B
Analysts84.44
Price Target166.6 (68.57%)
Short Float %6.37%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 3.33%
Yearly Dividend3
Dividend Growth(5Y)22.18%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-Date09-15 2025-09-15 (0.8)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.34%
Min EPS beat(2)-12.32%
Max EPS beat(2)15.01%
EPS beat(4)3
Avg EPS beat(4)3.64%
Min EPS beat(4)-12.32%
Max EPS beat(4)15.01%
EPS beat(8)5
Avg EPS beat(8)1.11%
EPS beat(12)9
Avg EPS beat(12)13.54%
EPS beat(16)13
Avg EPS beat(16)21.27%
Revenue beat(2)0
Avg Revenue beat(2)-2.32%
Min Revenue beat(2)-4.04%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-2.16%
Min Revenue beat(4)-4.04%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)3
Avg Revenue beat(12)-0.37%
Revenue beat(16)5
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)-1.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.24%
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-3.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.63%
Valuation
Industry RankSector Rank
PE 19.3
Fwd PE 17.11
P/S 2.18
P/FCF 20.03
P/OCF 14.52
P/B 3.78
P/tB 6.27
EV/EBITDA 10.07
EPS(TTM)5.12
EY5.18%
EPS(NY)5.78
Fwd EY5.85%
FCF(TTM)4.93
FCFY4.99%
OCF(TTM)6.81
OCFY6.89%
SpS45.42
BVpS26.13
TBVpS15.75
PEG (NY)14.81
PEG (5Y)0.87
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 19.18%
ROCE 22.81%
ROIC 16.62%
ROICexc 19.82%
ROICexgc 28.81%
OM 19.21%
PM (TTM) 11.03%
GM 56.34%
FCFM 10.86%
ROA(3y)10.68%
ROA(5y)8.79%
ROE(3y)21.16%
ROE(5y)17.18%
ROIC(3y)17.76%
ROIC(5y)14.62%
ROICexc(3y)22.72%
ROICexc(5y)19.96%
ROICexgc(3y)35.6%
ROICexgc(5y)32.29%
ROCE(3y)23.62%
ROCE(5y)19.43%
ROICexcg growth 3Y6.05%
ROICexcg growth 5Y-2.44%
ROICexc growth 3Y8.08%
ROICexc growth 5Y4.09%
OM growth 3Y3.91%
OM growth 5Y5.52%
PM growth 3Y4.43%
PM growth 5Y6.05%
GM growth 3Y0.16%
GM growth 5Y0.24%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.61
Debt/EBITDA 0.64
Cap/Depr 210.07%
Cap/Sales 4.12%
Interest Coverage 44.75
Cash Conversion 70.78%
Profit Quality 98.45%
Current Ratio 2.96
Quick Ratio 1.69
Altman-Z 5.36
F-Score5
WACC8.4%
ROIC/WACC1.98
Cap/Depr(3y)438.01%
Cap/Depr(5y)567.12%
Cap/Sales(3y)5.93%
Cap/Sales(5y)7.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.63%
EPS 3Y22.78%
EPS 5Y22.27%
EPS Q2Q%-13.16%
EPS Next Y1.3%
EPS Next 2Y5.2%
EPS Next 3Y6.32%
EPS Next 5YN/A
Revenue 1Y (TTM)7.04%
Revenue growth 3Y18.2%
Revenue growth 5Y15.27%
Sales Q2Q%-2.42%
Revenue Next Year2.09%
Revenue Next 2Y3.68%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
EBIT growth 1Y17.32%
EBIT growth 3Y22.82%
EBIT growth 5Y21.64%
EBIT Next Year9.75%
EBIT Next 3Y6.73%
EBIT Next 5YN/A
FCF growth 1Y246%
FCF growth 3YN/A
FCF growth 5Y20.52%
OCF growth 1Y45.26%
OCF growth 3Y16.2%
OCF growth 5Y19.66%